Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Natalia Ponomareva
Observed names:
N I PONOMAREVA,
N Ponomareva,
N. I. Ponomareva,
N. Ponomareva,
N.I. Ponomareva
Institutions:
Pirogov Russian National Research Medical University,
Russian Children's Clinical Hospital
Observed institutions:
Pirogov Russian National Research Medical University,
Russian Children's Clinical Hospital,
Ministry of Health of the Russian Federation,
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology,
City Clinical Hospital No 31
ORCID:
0000-0002-6499-0977
Observed ORCID:
0000-0002-6499-0977
OpenAlex ID:
A5042925696
Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy
2022
·
Alexandra Semchenkova
, Ekaterina Mikhailova
, et al.
·
International Journal of Molecular Sciences
·
40
PDF
Rituximab and reduced‐intensity chemotherapy in children and adolescents with mature B‐cell lymphoma: interim results for 231 patients enrolled in the second Russian‐Belorussian multicentre study B‐ NHL ‐2010M
2019
·
Alexey Maschan
, Natalia Myakova
, et al.
·
British Journal of Haematology
·
23
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia
·
18
Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002
2019
·
for the ALL-MB study group
, Alexander Karachunskiy
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
17
PDF
Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL
2024
·
Ekaterina Mikhailova
, Alexander Popov
, et al.
·
Journal for ImmunoTherapy of Cancer
·
16
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
14
Acute myeloid leukemia with t(10;11)(p11‐12;q23.3): Results of Russian Pediatric AML registration study
2019
·
Elena Zerkalenkova
, Svetlana Lebedeva
, et al.
·
International Journal of Laboratory Hematology
·
14
A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual disease measurement
2023
·
Alexander Popov
, Guenter Henze
, et al.
·
Pediatric Blood & Cancer
·
12
Genetic characteristics and treatment outcome in infants with KMT2A germline B‐cell precursor acute lymphoblastic leukemia: Results of MLL‐Baby protocol
2023
·
Alexander Popov
, Grigory Tsaur
, et al.
·
Pediatric Blood & Cancer
·
12
Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements
2021
·
Alexander Popov
, Grigory Tsaur
, et al.
·
British Journal of Haematology
·
12
Prognostic value of minimal residual disease measured by fusion‐gene transcript in infants with KMT2A‐rearranged acute lymphoblastic leukaemia treated according to the MLL‐Baby protocol
2021
·
Grigory Tsaur
, Alexander Popov
, et al.
·
British Journal of Haematology
·
11
PDF
Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002
2015
·
A Karachunskiy
, J Roumiantseva
, et al.
·
Leukemia
·
10
Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients
2021
·
Nikolay Mayanskiy
, Polina Luchkina
, et al.
·
Leukemia
·
9
PDF
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial
2023
·
Larisa Fechina
, Alexander Popov
, et al.
·
Leukemia
·
8
Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia Research
·
8
Treatment of acute lymphoblastic leukemia in adolescents and young adults: the experience of the Moscow–Berlin
2016
·
A. V. Pshonkin
, Yu. V. Rumyantseva
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
·
7
PDF
A single flow cytometric MRD measurement in children with B-lineage acute lymphocytic leukemia and hyperleukocytosis redefines the requirements of high-risk treatment: Results of the study ALL-MB 2008
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia Research
·
6
Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results
2022
·
A. Popov
, G. Henze
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
6
PDF
Prognostic significance of various 11q23/KMT2A rearrangements in infants with acute lymphoblastic leuekemia
2021
·
G. A. Tsaur
, T. O. Riger
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
6
PDF
Acute lymphoblastic leukemia in children with Down syndrome: comparative analysis of treatment results according to ALL-MB 2008 and ALL-MB 2015 protocols
2022
·
R. N. Suprun
, Yu. V. Rumyantseva
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
·
5
PDF
Incidence and prognostic value of central nervous system involvement in infants with B‐cell precursor acute lymphoblastic leukemia treated according to the MLL‐Baby protocol
2022
·
Alexander Popov
, Grigory Tsaur
, et al.
·
Pediatric Blood & Cancer
·
5
Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience
2021
·
R. N. Suprun
, Yu. V. Roumiantseva
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
5
PDF
The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience
2018
·
Y Y DYAKONOVA
, O I BYDANOV
, et al.
·
Terapevticheskii arkhiv
·
5
PDF
Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization
2015
·
N. V. Smirnova
, N. V. Myakova
, et al.
·
Oncohematology
·
5
PDF
Laboratory characterization of the pediatric B/T subtype of mixed-phenotype acute leukemia: Report of a case series
2024
·
Irina Demina
, Ekaterina Mikhailova
, et al.
·
American Journal of Clinical Pathology
·
4
PDF
Show more works
View as search
Works count:
39
Citation count:
295
H-index:
11
I10-index:
12
Year
Topic
Type